Tag Archives: Genentech

Avastin Users Wanted for New Research Study

Fight Colorectal Cancer is partnering together with 23andme and Genentech to help researchers better understand if patients’ genes play a role in how they respond to treatments they receive for their colorectal cancer.  This provides patients a new opportunity to participate in genetics research. You are invited to participate in the InVite Study. The InVite Study aims to enroll 1,000 individuals with certain types of advanced cancer who received Avastin before 2013. In order to participate you simply submit a saliva sample and complete some online surveys. The InVite Study will allow you to: Learn more about your health and genetic ancestry Take a direct role in research that may

Fake Avastin Discovered in US

The Food and Drug Adminstration and Genentech have reported that counterfeit Avastin is being distributed in the United States. The counterfeit medicine does not contain bevacizumab, Avastin’s active ingredient. The packaging is different from genuine Avastin marketed here by Genentech. It includes a Roche logo which isn’t on the real drug, along with different codes. Avastin is not in shortage now, and there are adequate supplies to meet the need. Patients being treated with Avastin are urged to let their doctors know immediately if they have unusual symptoms.

C-08 Avastin Trial Didn't Meet Primary Goal

When Avastin® (bevacizumab) was added to standard chemotherapy after surgery, it didn’t reduce the risk that early stage colon cancer would return, according to a press release this morning from Genentech. NSABP C-08 randomly assigned patients with stage II or III colon cancer to FOLFOX chemotherapy with or without additional Avastin.  During the Phase III clinical trial, all patients received FOLFOX (oxaliplatin, leucovorin, and infused 5-FU) every two weeks for six months.  Half also got Avastin with each treatment plus an additional six months of Avastin only. The study’s primary objective was disease-free survival, defined as lack of recurrence, another new cancer, or death for any reason.  According to Genentech, adding Avastin to

Top